Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Plos One|August 3, 2017
Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratoryMeenakshi Mehrotra, Dzifa Yawa Duose, Rajesh R Singh, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanomaWesley O Greaves, Shalini Verma, Keyur P Patel, et al.
Genes|March 28, 2025
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic LeukemiaQing Wei, Gokce A Toruner, Beenu Thakral, et al.
Annals of Diagnostic Pathology|September 25, 2020
Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphomaKirill A Lyapichev, Ali Sakhdari, Joseph D Khoury, et al.
The Journal of Molecular Diagnostics : JMD|July 2, 2013
Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genesRajesh R Singh, Keyur P Patel, Mark J Routbort, et al.
Cold Spring Harbor Molecular Case Studies|February 3, 2019
Hematologic malignancies and Li-Fraumeni syndromeMahesh Swaminathan, Sarah A Bannon, Mark Routbort, et al.
The Journal of Molecular Diagnostics : JMD|May 31, 2012
Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysisRajesh R Singh, Ashish Bains, Keyur P Patel, et al.
Cold Spring Harbor Molecular Case Studies|June 12, 2021
Incidental identification of inv(16)(p13.1q22)/CBFB-MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapyAndrés E Quesada, Rajyalakshmi Luthra, Elias Jabbour, et al.
Cancer Medicine|December 6, 2019
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVADAli Sakhdari, Beenu Thakral, Sanam Loghavi, et al.
Annals of Diagnostic Pathology|May 28, 2019
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variantAli Sakhdari, Chi Young Ok, Keyur P Patel, et al.
Pageof 23